The drug 'Monochinkwe'. Instructions for use

The drug "Monochinkwe" instructions for use refers to the category of nitrates and nitrate-like drugs. The active substance is isosorbide-5 mononitrate. The drug is available in the form of tablets and capsules.

The medicine lowers myocardial needs in oxygen. The drug "Monochinkwe" affects the coronary arteries, expanding them, and improves blood flow, contributing to the redistribution of blood in the ischemic departments. In addition, the drug helps to reduce the final diastolic volume of the left ventricle and reduce the systolic stress in its walls. Characterizing the therapeutic effect of the drug "Monochinkwe", the instruction for use indicates the properties of the drug to increase tolerance (tolerance) to physical exertion in patients with IHD, as well as to lower the pressure of the small circle of blood circulation.

Capsules "Monochinkwe-retard" are characterized by a delayed release of the active ingredient. This allows to ensure the optimal concentration of a single dose once a day. In this case, the therapeutic effect persists for twenty-four hours.

The drug "Monochinkwe" instructions for use recommends the use in the treatment and prevention of angina pectoris (for capsules additionally - angina pectoris of the third and fourth functional class). The drug is also shown in the recovery period as a treatment for heart failure (in combination with other drugs), as well as after a heart attack.

The drug "Monochinkwe" instruction does not admit to the appointment and reception for hemorrhagic stroke, with hypersensitivity, in the acute stage of a heart attack, with severe arterial hypotension. It is not recommended to take the remedy after TBI, at the age of up to eighteen years, with angle-closure glaucoma.

The expediency of using the drug during pregnancy is determined only by the doctor. If necessary, use medicament during lactation, feeding is stopped.

To the side effects of the "Monochinkwe" means the instruction for use refers to a headache (occurs at the beginning of therapy and is removed afterwards), after the first administration - a lowering of blood pressure or orthostatic hypotension complicated by weakness, dizziness, tachycardia. In rare cases, taking the medication causes an allergy on the skin, redness of the face, vomiting or nausea.

Assign the drug inside. Tablets and capsules should not be chewed. It is recommended to drink with a small amount of liquid.

Capsules are taken once a day. It is advisable to take the drug in the morning.

Tablets appoint one (or half a tablet) per day. Subsequently, according to the condition, the dosage can be adjusted.

The drug "Monochinkwe" is not used to stop (eliminate) an attack of angina pectoris.

Medication can be prescribed as an independent drug, or in combination with other drugs (beta-blockers, diuretics, cardiac glycosides and others).

It is established that the drug "Monochinkwe" influences the speed of the psychomotor reaction. In this regard, in the treatment process, it is recommended to refrain from engaging in activities considered to be potentially dangerous (for example, motor transport management).

The drug "Monochinkwe" is estimated by specialists as sufficiently effective. Particularly positive results were noted in patients who received the remedy after a heart attack in the recovery period. However, to achieve the maximum therapeutic effect, it is recommended that the doctor's recommendations be followed exactly. In addition, you need to carefully study the annotation.

The condition of the patient during treatment with the drug "Monochinkwe" should be regularly monitored by the doctor.